Prominent Companies - Rabies Vaccine Industry

Jun, 2023 - by CMI

Prominent Companies - Rabies Vaccine Industry

 

Rabies is a viral zoonotic disease caused through a dog’s bite which leads to progressive and fatal inflammation of the brain and spinal cord. There are two type of rabies; furious rabies and paralytic rabies. Symptoms accompanied with furious rabies are hyperactivity and hallucination.

Key players are focused on research and development strategies which are expected to drive the global  Rabies Vaccine market growth during the forecast period. For instance, in 2017, CPL Laboratories (India), a joint venture biotechnology company established in 2009 by Novavax Inc., USA and Cadila Pharmaceuticals Limited, stated that Nano- particle vaccine of baculvirous-derived glycoprotein, a four dose regime vaccine is in phase-3 human trial, and is expected to be approved by 2021.

Key Companies in the Rabies Vaccine Industry:

1) Serum Institute of India

Serum Institute of India is the world’s largest vaccine manufacturer and has produced and sold around 1.5 billion vaccines globally. The serum Institute of India was founded in 1966. Dr Cyrus Poonawalla incorporated this institution. The headquarters are located in Pune, Maharashtra. Over The years the company has produced many vaccines and its products have been used in various programmes ran by UNICEF, the World Health Organization.

In 2023 Serum Institute of India launched the first made in India qHPV vaccine “CERVAVAC”

2) Sanofi S.A.

Sanofi S.A. is a multinational pharmaceutical company that engages in the research and development, of pharmacological products, in the prescription market. The firm cover therapeutic areas like Cardiovascular, central nervous system, diabetes, internal medicine. The company was founded in 973 and the headquarters are located in Paris, France. Products manufactured include Medications, Genetic drugs, Vaccines, Animal Health, etc.

In December, 2022 Sanofi expanded its collaboration with Innate Pharma, with Sanofi licensing a natural killer (NK) cell nagger program targeting B7H3 from Innate’s ANKET platform.

3) Novartis AG

Novartis AG is a Swiss pharmaceutical corporation founded in March 1996 by Johann Rudolf The headquarters are located in Basel Switzerland, Cambridge, The United States of America and Massachusetts. It is one of the largest Pharma based company incorporated. The drugs manufactured are sold worldwide. Total revenue earned as of 2022 is US 50.545 billion dollars.

In June, 2022 Novartis completed the acquisition of Kedalion Therapeutics and its AcuStream technology.

4) GlaxoSmithKline GSK plc.

GSK Plc. Is a British Multinational pharmaceutical and biotechnology company founded in the year 2000. The headquarters are located in London, England, UK. GlaxoSmithKline is the tenth largest pharmaceutical company and has ranked 294th on the 2002 Fortune Globes 500. The company was founded by Joseph Nathan. The company manufacture products for major diseases like asthma, cancer, infections and mental health.

In April 2022, the company announced its plans of acquiring Sierra Oncology Inc. for U.S$ 1.9 Billion. In May 2022, GSK announced it would acquire Affinivax and its phase II 24- Valent pneumococcal vaccine candidate for up to $3.3 Billion.

5) Bharat Biotech International Limited (BBIL)

Bharat Biotech International Limited (BBIL) is an Indian multinational biotechnology company engaged in the drug discovery, drug development, and manufacture of vaccines, bio-therapeutics, pharmaceuticals and health care products. The company has been responsible for developing an eco-friendly recombinant and a naturally attenuated strain derived Rotavirus vaccine called ROTAVAC.

On October 12 2021, Bharat Biotech's Covaxin got approved for usage on children between 2 and 18 years of age

 

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.